The discussions have shown that communicable diseases are the main causes of illness, death and disability on the African continent. In this regard, the economic costs in terms of prevention, treatment and lost productivity are undeniably enormous. Most, if not all, human and financial resources allocated to Africa have focused on disease-specific intervention programs, such as the prevention or treatment of malaria, tuberculosis, and HIV/AIDS. Yellow fever, like malaria, is transmitted by mosquitoes and has similar characteristics. symptoms. While both diseases are preventable, there is a vaccine available for yellow fever. The yellow fever vaccine is expensive and not readily available in poor areas (Monath & Cetron, 2002). It is of concern to public health officials in Côte d'Ivoire when an outbreak occurred in January 2011 (Whittett, 2011). Because yellow fever occurs only in parts of Africa and tropical South America, Staples, Gerschman, and Fischer (2010) of the Centers for Disease Control (CDC) recommended that travelers to these areas get vaccinate. In African nations beset by economic instability and political unrest, the disease has brought its citizens untold hardship and indescribable suffering. It is sad to note that children under the age of fifteen are most often infected with the disease. The United Nations Children's Fund (UNICEF), the World Health Organization (WHO) and the World Bank have joined together to ensure that 33 African countries add the vaccine to its routine vaccination programmes. These organizations have demonstrated through studies that the vaccine would be cost-effective (Global Alliance for Vaccine and Immunizations, 2005). As highlighted, vaccine financing represents a major problem and concern for these poverty-stricken economies. WHO (2010) appeals for US$30 million to secure vaccine supplies for all 33 African countries from 2011 to 2015. The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) is an international financial organization fully funded by the developed nations of the world. The organization invests the world's money in interventions against AIDS, tuberculosis and malaria. To date, it has allocated $21.7 billion to 150 countries to support large-scale prevention, treatment and cure programs against the three diseases (The Global Fund, 2011). In southern Africa, the Global fund has allocated $2.